GlassScriptPhysician profile
Sarah N Sumner
NPI 1205398914
$1,924.70
in general payments reported to CMS, 2019-2025
23 companies · $531 in 2025
The $531 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $355 · 2022: $432 · 2023: $270 · 2024: $336 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,137.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $378.06 | 2021-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $262.05 | 2021-2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $223.99 | 2021-2025 | Airsupra, Farxiga |
| Pfizer INC. | $155.20 | 2022-2025 | |
| Csl Behring | $112.99 | 2022-2025 | Haegarda, Andembry |
| Lilly USA, LLC | $112.35 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $104.08 | 2021-2025 | |
| Dexcom, INC. | $71.99 | 2021-2025 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $68.51 | 2021-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $61.91 | 2022-2025 | |
| Corcept Therapeutics | $55.13 | 2024 | Korlym |
| Exact Sciences Corporation | $48.97 | 2024-2025 | Cologuard Collection Kit |
| Pharming Healthcare, INC. | $39.47 | 2021-2022 | |
| Amgen INC. | $34.84 | 2024 | Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.51 | 2024-2025 | Xifaxan |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $31.69 | 2023 | Takhzyro |
| Inspire Medical Systems, INC. | $27.46 | 2025 | Inspire |
| Biohaven Pharmaceuticals, INC. | $26.04 | 2021 | |
| Phathom Pharmaceuticals, INC. | $21.50 | 2025 | Voquezna |
| Kowa Pharmaceuticals America, INC. | $16.11 | 2022 | |
| Merck Sharp & Dohme LLC | $15.81 | 2023 | Verquvo, Belsomra, Steglatro |
| Inari Medical, INC. | $14.73 | 2022 | |
| Inogen, INC. | $7.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Sumner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.